Snowball logo
logo
CTXR_logo

Citius Pharmaceuticals, Inc

CTXR β€’ NASDAQ
$0.6037+$0.0283Β  (4.92%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
-----7.105197
COGS
0.1648680.1796770.1943160.2096110.214253.965716
Gross Profit
(0.164868)(0.179677)(0.194316)(0.209611)(0.21425)3.13948
Operating Expenses & Income
Operating Income
(23.53)(33.32)(36.73)(42)(38.53)(60.89)
Total Operating Expenses
23.5333.3236.734238.3164.03
R&D Expenses
12.2417.6614.8211.919.1564745.928692
Selling General & Admin Expenses
11.2915.6621.9118.2518.5339.45
Earnings from Continuing Operations
Interest Expense
(0.0108)(0.251399)--(0.267782)(0.515821)
Interest Income
0.2618250.2513991.1794170.7580.1100810.152104
Income Tax Expense
0.07080.5760.5760.5761.056960.189923
Net Income
Net Income
(23.13)(33.64)(32.54)(39.14)(37.43)(49.33)
Supplemental
EBIT
(23.04)(33.06)(31.97)(38.85)(38.42)-
EBITDA
(22.88)(32.88)(31.77)(38.64)(38.2)(58.44)
In millions of USD, except % and values per 1 share